A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
Status:
Recruiting
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
This is an open, single-arm, multi-center clinical study designed to evaluate the efficacy
and safety of TQ05105 Tablets combined with TQB3617 Capsules in patients with intermediate-
and high-risk Myelofibrosis.